GMP Quality Concerns Prompt Indian Drug Regulator To Plan Overseas Site Inspections, Mainly In China
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - As part of plans to beef up checks of imported drugs and intermediates, the Drug Controller General of India is proposing to send its own agents to large manufacturing plants across the world to inspect and establish compliance with good manufacturing practice standards